White Paper
An Analysis of COVID-19 Vaccines and the Need for Post-Vaccination Risk Mitigation Protocols
The availability of COVID-19 vaccines from Pfizer, Moderna, and Johnson & Johnson does not automatically mean a return to normal life. This paper will explain why risk mitigation tactics are still needed and what tactics you should take to reduce infection from COVID-19 even after vaccination.
Read this report to learn:
- Two limitations of the Pfizer and Moderna vaccines
- Risk mitigation tactics you should use to reduce the spread of COVID-19
Register Now to Download


22 Roulston Rd. Windham, NH 03087
(603) 893-0419